Study on the mechanism of liver cancer immune escape mediated by MINDY1 through regulation of PD-L1 ubiquitination level
2025

Study on Liver Cancer Immune Escape Mechanism Involving MINDY1 and PD-L1

Sample size: 50 publication 10 minutes Evidence: moderate

Author Information

Author(s): Song Xingchao, Li Wenjin, Tian Chunyan, Ma Xiao, Yang Weibin, Zhou JiaHua

Primary Institution: The Affiliated Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China

Hypothesis

MINDY1 mediates immune escape in liver cancer by regulating PD-L1 ubiquitination.

Conclusion

MINDY1 inhibits PD-L1 ubiquitination, which helps prevent the malignant progression of liver cancer.

Supporting Evidence

  • MINDY1 and PD-L1 levels were higher in cancer tissues compared to adjacent tissues.
  • High expression of MINDY1 correlated with lower 5-year tumor-free survival rates.
  • MINDY1 knockdown increased PD-L1 ubiquitination.
  • MINDY1 directly interacts with PD-L1.

Takeaway

This study found that a protein called MINDY1 helps liver cancer cells avoid the immune system by affecting another protein called PD-L1.

Methodology

The study involved examining tissue samples from 50 liver cancer patients and conducting various cellular experiments to assess the roles of MINDY1 and PD-L1.

Potential Biases

Potential bias due to the small sample size and lack of diverse patient demographics.

Limitations

The study's sample size was limited, which may affect the generalizability of the findings.

Participant Demographics

50 hepatocellular carcinoma patients, specific demographics not detailed.

Statistical Information

P-Value

0.027 for MINDY1, 0.001 for PD-L1

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.17305/bb.2024.10962

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication